Manuscripts
Showing 1554 manuscripts.
Management of cytomegalovirus disease with antiviral drugs
Citation
Henry H. Balfour. Management of cytomegalovirus disease with antiviral drugs. Reviews of Infectious Diseases. 1990. 12: S849-60.Year
1990
Journal
Reviews of Infectious Diseases
Interleukin-2 in the treatment of HIV disease
Citation
David H. Schwartz, Thomas C. Merigan. Interleukin-2 in the treatment of HIV disease. Biotherapy. 1990. 2: 119-36.Year
1990
Journal
Biotherapy
Adjusting for early treatment termination in comparative clinical trials
Citation
Stephen W. Lagakos, Lony C.L. Lim, J. Robins. Adjusting for early treatment termination in comparative clinical trials. Statistics In Medicine. 1990. 9: 1417-24.Year
1990
Journal
Statistics In Medicine
Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis
Citation
Greg Spear, Brenda L. Sullivan, Alan Landay, T. F. Lint. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. Journal of Virology. 1990. 64: 5869-73.Year
1990
Journal
Journal of Virology
A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients
Citation
Gildon Beall, Sally Kruger, F. Morales, D. Imagawa, J. A. Goldsmith, D. Fisher, James Paul Steinberg, John P. Phair, S. Whaling, J. Bitran. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients. AIDS. 1990. 4: 679-81.Year
1990
Journal
AIDS
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group
Citation
Richard B. Roberts, F. Blaine Hollinger, Wade P. Parks, Suraiya Rasheed, J. Laurence, Peter Heseltine, R. W. Makuch, J. A. Lubina, Kristine M.C. Johnson. A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group. AIDS. 1990. 4: 67-72.Year
1990
Journal
AIDS
HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages
Citation
O. Selnes, Eric N. Miller, Justin C. McArthur, B. Gordon, A. Munoz, K. Sheridan, Raymond Fox, Alfred J. Saah. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology. 1990. 40: 204-8.Year
1990
Journal
Neurology
Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detection
Citation
M. Hassanzadeh, Francesca Aweeka, Shirley (Xingye) Wu, Mark A. Jacobson, John G. Gambertoglio. Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detection. Journal of Liquid Chromatography. 1990. 525: 133-40.Year
1990
Journal
Journal of Liquid Chromatography
Semiquantitative technique for estimating Pneumocystis carinii burden in the lung
Citation
Robert Baughman, Susan Strohofer, Gregory Colangelo, Peter T. Frame. Semiquantitative technique for estimating Pneumocystis carinii burden in the lung. Journal of Clinical Microbiology. 1990. 28: 1425-7.Year
1990
Journal
Journal of Clinical Microbiology
Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas
Citation
J. Brajtburg, Svetlana Elberg, Kenneth B. Schechtman, Gerald Medoff. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas. Cancer Research. 1990. 50: 3274-8.Year
1990
Journal
Cancer Research